Comparison of the effects of specific and nonspecific inhibition of nitric oxide synthase on morphine analgesia, tolerance and dependence in mice

Life Sciences

Volumn 72, Issue 17, 2003, Pages 1943-1951

  Özek, Mehmet ^a   Üresin, Yaǧiz ^a   Güngör, Mehmet ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Analgesia; Dependence; L Canavanine; L NAME; Morphine; Nitric oxide synthase (NOS); Tolerance

Indexed keywords

CANAVANINE; MORPHINE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG PELLET; DRUG POTENTIATION; DRUG WITHDRAWAL; ENZYME INHIBITION; IMPLANTATION; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; WEIGHT REDUCTION;

EID: 0037436749     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00100-0     Document Type: Article

References (33)

1. G-nitro-L-arginine methyl ester. Life Sciences. 52:1993;PL245-PL249.
2. Allen R.M., Dykstra L.A. Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance magnitude. Journal of Pharmacology and Experimental Therapeutics. 295:2000;1012-1021.
3. Bredt D.S., Synder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proceedings of the National Academy of Sciences of the United States of America. 86:1989;9030-9033.
4. Curtis D.R., Watkins J.C. The pharmacology of amino acids related to gamma-aminobutyric acid. Pharmacological Reviews. 17:1965;347-391.
5. Dambisya Y.M., Lee T.L. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. British Journal of Pharmacology. 117:1996;914-918.
6. Garthwaite J. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends in Neurosciences. 14:1991;60-67.
7. Garthwaite J., Boulton C.L. Nitric oxide signaling in the central nervous system. Annual Review of Physiology. 57:1995;683-706.
8. Gibson R.D., Tingstad J.E. Formulation of a morphine implantation pellet suitable for tolerance-physical dependence studies in mice. Journal of Pharmaceutical Sciences. 59:1970;426-427.
9. Gonzalez P., Cabello P., Germany A., Norris B., Contreras E. Decrease of tolerance to and physical dependence on morphine by glutamate receptor antagonist. European Journal of Pharmacology. 332:1997;257-262.
10. Haley J.E., Dickenson A.H., Schachter M. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology. 31:1992;251-258.
11. Higgins G.A., Nguyen P., Sellers E.M. The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal. Life Sciences. 50:1992;PL167-PL172.
12. Iyengar R., Stuehr D.J., Marletta M.A. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proceedings of the National Academy of Sciences of the United States of America. 84(18):1987;6369-6373.
13. Knowles R.G., Palacios M., Palmer R.M.J., Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proceedings of the National Academy of Sciences of the United States of America. 86:1989;5159-5162.
14. Kolesnikov Y., Pan Y.X., Babey A.M., Jain S., Wilson R., Pasternak G.W. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proceedings of the National Academy of Sciences of the United States of America. 94:1997;8220-8225.
15. Koyuncuoǧlu H. The treatment with dextromethorphan of heroin addicts. Loimer N., Schmidt R., Springer A. Drug addiction and AIDS. 1991;320-329 Springer, Vienna.
16. Koyuncuoǧlu H., Genç E., Güngör M., Eroǧlu L., Saǧduyu H. The antagonizing effect of aspartic acid on the brain levels of monoamines and free amino acids during the development of physical dependence on morphine. Psychopharmacology (Berlin). 54:1977;187-191.
17. Koyuncuoǧlu H., Güngör M., Eroǧlu L., Saǧduyu H. The antagonizing effect of aspartic acid on morphine withdrawal and levallorphan-precipitated abstinence syndrome signs and on associated changes levels of free amino acids in the rat. Psychopharmacology (Berlin). 62:1979;89-95.
18. Koyuncuoǧlu H., Güngör M., Saǧduyu H., Eroǧlu L. The antagonistic effects of aspartic acid on some effects of morphine on rats. European Journal of Pharmacology. 27:1974;148-150.
19. Koyuncuoǧlu H., Saydam B. The treatment of heroin addicts with dextromethorphan: a double-blind comparison of dextromethorphan with chlorpromazine. International Journal of Clinical Pharmacology, Therapy, and Toxicology. 28:1990;147-152.
20. Lin H.C., Kang B.H., Wan F.D., Huang S.T., Tseng C.J. Reciprocal regulation of nitric oxide and glutamate in the nucleus tractus solitarii of rats. European Journal of Pharmacology. 407:2000;83-89.
21. Majeed N.H., Przewlocka B., Machelska H., Przewlocki R. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology. 33:1994;189-192.
22. Marek P., Ben Eliyahu S., Gold M., Liebeskind J.C. Excitatory amino acid antagonist (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Research. 547:1991;77-81.
23. Medvedev I.O., Dravolina D.A., Bespalov A.Y. Differential effects of nitric oxide synthase inhibitor, 7-nitroindazole, on discriminative stimulus and somatic effects of naloxone in morphine-dependent rats. European Journal of Pharmacology. 377:1999;183-186.
24. Medvedev I.O., Dravolina O.A., Bespalov A.Y. Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm. Journal of Pharmacology and Experimental Therapeutics. 286:1998;1260-1268.
25. O'Callaghan J.P., Holtzman S.G. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure. Journal of Pharmacology and Experimental Therapeutics. 192:1975;497-505.
26. Pataki I., Telegdy G. Further evidence that nitric oxide modifies acute and chronic morphine actions in mice. European Journal of Pharmacology. 357:1998;157-162.
27. Stuehr DJ, Griffith OW. Mammalian nitric oxide synthases 1992;65:287-346.
28. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
29. Umans J.G., Samsel R.W. L-canavanine selectively augments contraction in aortas from endtoxemic rats. European Journal of Pharmacology. 210(3):1992;343-346.
30. Vaupel B.D., Kimer A.S., London E.D. Nitric oxide synthase inhibitors: preclinical studies of potential use for treatment of opioid withdrawal. Neuropharmacology. 13:1995;315-322.
31. Vaupel B.D., Kimer A.S., London E.D. Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy. European Journal of Pharmacology. 324:1997;11-20.
32. Watkins J.C., Evans R.H. Excitatory amino acid transmitters. Annual Review of Pharmacology and Toxicology. 21:1981;165-204.
33. Way E.L., Loh H.H., Shen F.H. Simultaneous quantitative assessment of morphine tolerance and physical dependence. Journal of Pharmacology and Experimental Therapeutics. 167:1969;1-8.